NSPR compared with CRBP: revenue, margins and what each company keeps, and the suppliers and customers both name

NSPRInspireMD, Inc.

Mkt capRevenueRevenue

CRBPCorbus Pharmaceuticals Holdings, Inc.

Mkt capRevenueRevenue

Compare

NSPRInspireMD, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NSPR1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−10.44%—

CRBP1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▲+1.78%×0.12

= impliedNSPR realized, solidCRBP realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

NSPRInspireMD, Inc.

0.45▼−0.33%· post 0.45

Mkt cap$20.9MRevenue$2MQ2 FY26Revenue$9MFY25

CRBPCorbus Pharmaceuticals Holdings, Inc.

4.20▼−0.43%· post 4.20

ClosedOct 30 '26

Mkt cap$81.6MRevenue$1MQ2 FY26Revenue$6MFY25

Compare

ClosedOct 30 '26

NSPRInspireMD, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.

0.45▼−0.33%post 0.45

Price

4.20▼−0.43%post 4.20

$20.9M

Mkt cap

$81.6M

Q2 FY26$2M

Revenue

$1MQ2 FY26

FY25$9M

Revenue

$6MFY25

NSPR0.45▼−0.33%vsCRBP4.20▼−0.43%ClosedOct 30 '26